Case number 1:21-cv-00314
Bayer Pharma AG et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 9, 2024 | 164 | Answer to Complaint and Counterclaims (D.I. 10 in 24-cv-138-RGA; D.I. 10 in 24-cv-138-RGA), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 4/10/2024 (nms). (Entered: 04/09/2024) (9) |
| Apr 2, 2024 | 163 | SO ORDERED Granting (D.I. 162 in 21-cv-314-RGA-LDH; D.I. 13 in 24-cv-138-RGA; D.I. 255 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 4/2/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:24-cv-00138-RGA(nms) (Entered: 04/02/2024) (4) |
| Apr 1, 2024 | 162 | STIPULATION and Order Regarding Consolidation and Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 04/01/2024) (4) |
| Mar 8, 2024 | 161 | Joint Status Report Regarding Stay, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/11/2024 (nms). (Entered: 03/08/2024) (5) |
| Dec 22, 2023 | 160 | NOTICE requesting Clerk to remove Elham Firouzi Steiner as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Moore, David) (Entered: 12/22/2023) (2) |
| Dec 15, 2023 | 158 | STIPULATION and [Proposed] Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/15/2023 (nms). (Entered: 12/15/2023) (3) |
| Dec 15, 2023 | 159 | SO ORDERED Granting (D.I.158 in 21-cv-314-RGA-LDH; D.I. 14 in 23-cv-1196-RGA; D.I. 202 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule: Civil Action 23-1196-RGA is consolidated with Civil Action 21 314-RGA-JLH for all purposes, including for trial. All papers shall be filed in Civil Action 21-314-RGA-JLH (see Order for further details). Signed by Judge Richard G. Andrews on 12/15/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:23-cv-01196-RGA(nms) (Entered: 12/15/2023) (3) |
| Oct 6, 2023 | 157 | NOTICE requesting Clerk to remove Ty W. Callahan as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Palapura, Bindu) (Entered: 10/06/2023) (2) |
| Sep 25, 2023 | 156 | Answer to Counterclaims of Defendant Teva Pharmaceuticals USA, Inc.,filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Blumenfeld, Jack) Modified on 9/25/2023 (nms). (Entered: 09/25/2023) (8) |
| Sep 15, 2023 | 154 | STIPULATION and [Proposed] Order Regarding Consolidation and Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/15/2023) (3) |
| Sep 15, 2023 | 155 | SO ORDERED Granting (D.I. 188 in 21-md-3017-RGA; D.I. 16 in 23-cv-551-RGA; D.I. 154 in 21-cv-314-RGA-JLH) Stipulation and Proposed Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 9/15/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:23-cv-00551-RGA(nms) (Entered: 09/15/2023) (3) |
| Sep 8, 2023 | 152 | STIPULATION and [Proposed] Order Regarding Stay - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/08/2023) (4) |
| Sep 8, 2023 | 153 | SO ORDERED Granting (D.I. 13 in 23-cv-410-RGA; D.I. 186 in 21-md-3017-RGA; D.I. 126 in 21-cv-1742-RGA; D.I. 152 in 21-cv-314-RGA-JLH) Stipulation and Proposed Order Regarding Stay. Signed by Judge Richard G. Andrews on 9/8/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:23-cv-00410-RGA(nms) (Entered: 09/08/2023) (4) |
| Sep 1, 2023 | 151 | STIPULATION and Proposed Order to Extend Time to file Joint Status Report to September 8, 2023 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan) Modified on 9/1/2023 (nms). (Entered: 09/01/2023) (3) |
| Aug 25, 2023 | 150 | STIPULATION and Proposed Order to Extend Time for the parties to provide a joint status report - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/25/2023 (lah). (Entered: 08/25/2023) (3) |
| Aug 11, 2023 | 149 | STIPULATION and Proposed Order to Extend Time to provide a Joint Status Report by August 25, 2023, filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Main Document 149 replaced on 8/11/2023) (nms). Modified on 8/11/2023 (nms). (Entered: 08/11/2023) (4) |
| Aug 10, 2023 | 148 | NOTICE of Service of Change of Address for J.C. Rozendaal, Chandrika Vira, and Brady Gleason of Sterne, Kessler, Goldstein & Fox, P.L.L.C. by Teva Pharmaceuticals USA, Inc. (DiBenedetto, Emily) Modified on 8/15/2023 (nms). (Entered: 08/10/2023) (2) |
| Jun 20, 2023 | 147 | SO ORDERED Granting (D.I. 155 in 21-md-3017-RGA; D.I. 146 in 21-cv-314-RGA-JLH; D.I. 18 in 22-cv-1596-RGA) Stipulation and Order Regarding Consolidation and Scheduled. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:22-cv-01596-RGA(nms) (Entered: 06/20/2023) (5) |
| Jun 2, 2023 | 146 | STIPULATION and Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). (Entered: 06/02/2023) (5) |
| Mar 17, 2023 | 145 | NOTICE of Withdrawal of Appearance of Delaware Counsel, Eve Ormerod by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve) (Entered: 03/17/2023) (1) |
| Jan 18, 2023 | 144 | ORAL ORDER: For the reasons stated on the record on January 18, 2023, a stay of the case is GRANTED until fourteen days after the PTAB issues a final written decision on the related IPR. At that time, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. The motion to extend schedule (D.I. 125) is DISMISSED as moot. Ordered by Judge Richard G. Andrews on 1/18/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 01/18/2023) (0) |
| Jan 6, 2023 | 143 | ORAL ORDER: A hearing on the Motion to Extend Schedule (D.I. 134 in 21-cv-314-RGA-JLH; D.I. 113 in 21-cv-1742-RGA; D.I. 125 in 21-md-3017-RGA) is now set for 1/18/2023, at 10:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 1/6/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 01/06/2023) (0) |
| Jan 3, 2023 | 142 | Letter to The Honorable Richard G. Andrews, from Emily S. DiBenedetto, regarding request for oral argument. (DiBenedetto, Emily) Modified on 1/4/2023 (nms). (Entered: 01/03/2023) (1) |
| Dec 27, 2022 | 141 | REPLY Brief in further support of 134 MOTION to Extend Schedule, filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Hoeschen, Nathan) Modified on 12/28/2022 (nms). (Entered: 12/27/2022) (Main Document) (6) |
| Dec 27, 2022 | 141 | REPLY Brief in further support of 134 MOTION to Extend Schedule, filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Hoeschen, Nathan) Modified on 12/28/2022 (nms). (Entered: 12/27/2022) (Exhibit A) (8) |
| Dec 16, 2022 | 140 | ANSWERING BRIEF in Opposition re 134 MOTION to Extend Schedule - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/27/2022. (Fahnestock, Derek) (Entered: 12/16/2022) (13) |
| Dec 14, 2022 | 139 | NOTICE of Withdrawal of Motion to Extend Schedule (D.I. 134 ), by Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s. (Ormerod, Eve) Modified on 12/14/2022 (nms). (Entered: 12/14/2022) (1) |
| Dec 13, 2022 | 137 | STIPULATION and [Proposed] Order to Extend Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 12/13/2022) (4) |
| Dec 13, 2022 | 138 | STIPULATION and Proposed Order to Extend Time to file their response to Defendants' Motion to Extend Schedule - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/13/2022 (nms). (Entered: 12/13/2022) (3) |
| Dec 2, 2022 | 136 | NOTICE OF SERVICE of (1) Plaintiff Bayer's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) and (2) Plaintiff Janssen's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 12/02/2022) (9) |
| Dec 1, 2022 | 135 | MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 12/01/2022) (3) |
| Nov 29, 2022 | 134 | MOTION to Extend Schedule - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 11/29/2022 (nms). (Entered: 11/29/2022) (6) |
| Nov 16, 2022 | 132 | STIPULATION and Order regarding Infringement by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 11/16/2022) (3) |
| Nov 16, 2022 | 133 | SO ORDERED Granting (D.I. 123 in 21-md-3017-RGA; D.I.132 in 21-cv-314-RGA-JLH) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 11/16/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 11/16/2022) (3) |
| Nov 14, 2022 | 131 | NOTICE requesting Clerk to remove David M. Knapp as co-counsel.. (Vrana, Robert) (Entered: 11/14/2022) (4) |
| Nov 11, 2022 | 130 | NOTICE of Change of Firm Affiliation by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc. (Vrana, Robert) (Entered: 11/11/2022) (4) |
| Nov 2, 2022 | 126 | NOTICE to Take Deposition of Nancy Cook Bruns filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (4) |
| Nov 2, 2022 | 127 | NOTICE to Take Deposition of Frank Misselwitz filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (4) |
| Nov 2, 2022 | 128 | NOTICE to Take Deposition of Bayer Pharma AG and Bayer AG filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (10) |
| Nov 2, 2022 | 129 | NOTICE to Take Deposition of Janssen Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (10) |
| Oct 20, 2022 | 125 | NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) (Entered: 10/20/2022) (3) |
| Oct 19, 2022 | 124 | SO ORDERED Granting (D.I. 123 in 21-cv-314-RGA-JLH; D.I. 112 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/19/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 10/19/2022) (3) |
| Oct 18, 2022 | 121 | NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 10/18/2022) (2) |
| Oct 18, 2022 | 122 | NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s Identification References & Combinations filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Belgam, Neal) (Entered: 10/18/2022) (2) |
| Oct 18, 2022 | 123 | STIPULATION and Order Regarding Infringement (as to Defendants Lupin Limited and Lupin Pharmaceutical, Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 10/18/2022) (3) |
| Oct 17, 2022 | 120 | NOTICE OF SERVICE of Defendants' Prior Art Narrowing Disclosure (also filed on behalf of Defendant Teva Pharmaceuticals USA, Inc.) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/17/2022) (2) |
| Oct 12, 2022 | 119 | SO ORDERED Granting (D.I. 117 in 21-cv-314-RGA-JLH; D.I. 102 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 10/12/2022) (3) |
| Oct 11, 2022 | 117 | STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 10/11/2022) (3) |
| Oct 11, 2022 | 118 | SO ORDERED Granting (D.I. 116 in 21-cv-314-RGA-JLH; D.I. 101 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/11/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 10/11/2022) (3) |
| Oct 7, 2022 | 116 | STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/11/2022 (nms). (Entered: 10/07/2022) (3) |
| Sep 30, 2022 | 115 | Joint Stipulation and [Proposed] Order to Extend Time, by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 9/30/2022 (nms). (Entered: 09/30/2022) (4) |
| Sep 19, 2022 | 106 | NOTICE to Take Deposition of Shobha Chagam on October 3, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 107 | NOTICE to Take Deposition of Sowjanya Madala on October 10, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 108 | NOTICE to Take Deposition of Srinivasa Rao on October 17, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 109 | NOTICE to Take Deposition of Jason Gensburger on October 4, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 110 | NOTICE to Take Deposition of Pramod Dahibhate on October 11, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 111 | NOTICE to Take Deposition of Makrand Avichat on October 18, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 112 | NOTICE to Take Deposition of Avi Avramoff on October 5, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 113 | NOTICE to Take Deposition of Miriam Getsis on October 12, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 114 | NOTICE to Take Deposition of Natalie Yantovskiy on October 19, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 12, 2022 | 105 | NOTICE OF SERVICE of (1) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.; (2) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.; (3) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.; and (4) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendant Teva Pharmaceuticals USA, Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/12/2022) (7) |
| Sep 9, 2022 | 103 | NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s First Supplemental Objections and Responses to Plaintiffs Bayer Pharma AG and Janssen Pharmaceuticals, Inc.s First Joint Set of Interrogatories filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) (Entered: 09/09/2022) (2) |
| Sep 9, 2022 | 104 | MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek) (Entered: 09/09/2022) (8) |
| Sep 8, 2022 | 101 | MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) (Entered: 09/08/2022) (3) |
| Sep 8, 2022 | 102 | STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 09/08/2022) (3) |
| Sep 7, 2022 | 97 | NOTICE to Take Deposition of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022) (8) |
| Sep 7, 2022 | 98 | NOTICE to Take Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022) (8) |
| Sep 7, 2022 | 99 | NOTICE to Take Deposition of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022) (8) |
| Sep 7, 2022 | 100 | NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022) (8) |
| Aug 30, 2022 | 96 | NOTICE of Change of Address by Megan C. Haney (Haney, Megan) (Entered: 08/30/2022) (1) |
| Aug 24, 2022 | 94 | STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 9, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 08/24/2022) (3) |
| Aug 24, 2022 | 95 | SO ORDERED, re (D.I. 94 in 21-cv-1742-RGA; D.I. 70 in 21-md-3017-RGA; 94 in 21-cv-314-RGA-JLH) STIPULATION to Extend Time for Plaintiffs and Defendants to substantially complete document production to September 9, 2022. Signed by Judge Richard G. Andrews on 8/24/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 08/24/2022) (0) |
| Aug 5, 2022 | 93 | NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) and (2) Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 08/05/2022) (4) |
| Jul 27, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 68 in 21-md-3017-RGA; D.I. 92 in 21-cv-314-RGA-JLH; D.I.93 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/27/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| Jul 26, 2022 | 92 | Stipulation to EXTEND Time (3) Docket Text: Joint Stipulation and Proposed Order to Extend Time - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve) Modified on 7/27/2022 (nms). |
| Jul 12, 2022 | 91 | Order (2) Docket Text: SO ORDERED Granting (D.I. 66 in 21-md-3017-RGA; D.I. 90 in 21-cv-314-RGA-JLH) Stipulation of Dismissal (*Micro Labs USA, Inc. and Micro Labs Limited terminated). Signed by Judge Richard G. Andrews on 7/12/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| Jul 6, 2022 | 89 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's First Set of Requests for Production to Plaintiffs (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) |
| Jul 6, 2022 | 90 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal with prejudice, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/7/2022 (nms). |
| Jul 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 88 in 21-cv-314-RGA-JLH; D.I. 64 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order (between Plaintiffs and Defendants "Micro"). Signed by Judge Richard G. Andrews on 7/1/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) |
| Jul 1, 2022 | 88 | Stipulation (2) Docket Text: STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Hitch, Cortlan) Modified on 7/1/2022 (nms). |
| Jun 27, 2022 | 87 | Order (2) Docket Text: SO ORDERED Granting (D.I. 62 in 21-md-3017-RGA: D.I. 86 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/27/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| Jun 24, 2022 | 86 | Stipulation (2) Docket Text: STIPULATION Amend Scheduling Order as to Plaintiffs and Micro Labs by Micro Labs Ltd.. (Hitch, Cortlan) |
| Jun 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 61 in 21-md-3017-RGA; D.I. 85 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 6/10/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| Jun 10, 2022 | 85 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) |
| Jun 9, 2022 | 84 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Appearance of Anandita Vyakarnam by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve) |
| Jun 8, 2022 | 83 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s 1) Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) and 2) Responses and Objections to Plaintiffs' First Joint Set of Interrogatories (Nos. 1-7) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) |
| Jun 7, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The notice of service filed at D.I. 79 has been removed from the docket as the filing lacked reference to the MDL that this case is a member with. Defendants are to refile a corrected notice. (nms) |
| Jun 7, 2022 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Teva's Objections and Responses to Plaintiffs' First Set of Interrogatories 2. Teva's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1 - 43) filed by Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 7, 2022 | 82 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Joint Set of Interrogatories; and 2) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Set of Requests for Production filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) |
| Jun 6, 2022 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) and Lupin's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) |
| Jun 2, 2022 | 77 | Stipulation (2) Docket Text: STIPULATION to Amended Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) |
| Jun 2, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 77 in 21-cv-314-RGA-JLH; D.I. 53 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/2/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| Jun 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Frank D. Rodriguez for Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 1, 2022 | 76 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); (2) Plaintiffs Bayer Pharma AG and Bayer AG's Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9); (3) Plaintiff Janssen Pharmaceutical Inc.'s Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| May 31, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 51 in 21-md-3017-RGA; D.I. 75 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 5/31/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| May 31, 2022 | 75 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) |
| May 25, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 74 in 21-cv-314-RGA-JLH; D.I. 50 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp, filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 5/25/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| May 25, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David M. Knapp for Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 71 in 21-cv-314-RGA-JLH; D.I. 47 in 21-md-3017-RGA; D.I. 88 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time to Submit Joint Claim Construction Chart to May 24, 2022. Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 24, 2022 | 72 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order regarding claim construction, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/24/2022 (nms). |
| May 24, 2022 | N/A | Order (0) Docket Text: SO ORDERED Granting (D.I. 89 in 21-cv-1742-RGA; D.I. 72 in 21-cv-314-RGA-JLH; D.I. 48 in 21-md-3017-RGA) Stipulation and Proposed Order regarding claim construction (*The Markman hearing scheduled for 8/23/2022 is CANCELED). Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 24, 2022 | 74 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) |
| May 23, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 46 in 21-md-3017-RGA; D.I. 70 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/23/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| May 23, 2022 | 70 | Stipulation (2) Docket Text: STIPULATION to Amend the Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) |
| May 23, 2022 | 71 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to May 24, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan) |
| May 20, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 45 in 21-md-3017-RGA; D.I. 69 in 21-cv-314-RGA-JLH; D.I. 87 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022. Signed by Judge Richard G. Andrews on 5/20/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 19, 2022 | 69 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| May 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 85 in 21-cv-1742-RGA; D.I. 68 in 21-cv-314-RGA-JLH; D.I. 43 in 21-md-3017-RGA) STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) |
| May 17, 2022 | 68 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms). |
| May 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 66 in 21-cv-314-RGA-JLH; D.I. 40 in 21-md-3017-RGA) STIPULATION to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) |
| May 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 83 in 21-cv-1742-RGA; D.I. 41 in 21-md-3017-RGA; D.I. 67 in 21-cv-314-RGA-JLH) STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 13, 2022 | 66 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME various dates to dates listed in stipulation - filed by Micro Labs Ltd., Micro Labs USA Inc., Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth) |
| May 13, 2022 | 67 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| May 2, 2022 | 64 | Notice (Other) (6) Docket Text: NOTICE of Change of Address for Williams & Connolly LLP by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc. (Fahnestock, Derek) |
| May 2, 2022 | 65 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Identification of Claim Terms and Constructions filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) |
| Apr 29, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [62] Stipulation to Amend Scheduling Order between Plaintiffs and Defendants Micro Labs Limited and Micro Labs USA, Inc.. Signed by Judge Richard G. Andrews on 4/29/2022. (nms) |
| Apr 29, 2022 | 62 | Stipulation (2) Docket Text: STIPULATION to Amended Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) Modified on 4/29/2022 (nms). |
| Apr 29, 2022 | 63 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Apr 22, 2022 | 61 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Joint Set of Interrogatories to Defendants, (2) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., (3) Plaintiffs' First Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc., (4) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (5) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (6) Plaintiffs' First Set of Requests for Production to Defendants Micro Labs Ltd. and Micro Labs USA, Inc., and (7) Plaintiffs' First Set of Requests for Production to Defendants Mylan Pharmaceuticals, Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Apr 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 59 in 21-cv-314-RGA-JLH; D.I. 33 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) |
| Apr 18, 2022 | 59 | Stipulation (2) Docket Text: STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs) by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) |
| Apr 18, 2022 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set Of Joint Interrogatories To Plaintiffs (Nos. 1-9); and Defendants' First Set Of Joint Requests For Production To Plaintiffs (Nos. 1-60) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) |
| Apr 15, 2022 | 58 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery and (2) Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delawares Default Standard for Discovery - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Apr 1, 2022 | 57 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Initial Disclosures, (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures, and (3) Bayer Pharma AG, Bayer AG's, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Mar 28, 2022 | 56 | Objections (9) Docket Text: Answer to Counterclaims of Defendants Micro Labs Ltd. and Micro Labs USA, Inc. (see C.A. 22-165-RGA, D.I. 10), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/28/2022 (nms). |
| Mar 22, 2022 | N/A | Remark (0) Docket Text: Remark: Civil Action 22-165-RGA has been added as a consolidated case per filing D.I. 13 on that docket. (nms) |
| Mar 2, 2022 | 54 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Moore, David) |
| Mar 2, 2022 | 55 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) |
| Mar 1, 2022 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Joint Initial Invalidity Contentions with Ex. A filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) |
| Jan 28, 2022 | 49 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for DRL's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Jan 28, 2022 | 50 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Lupin's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Jan 28, 2022 | 51 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Taro's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Jan 28, 2022 | 52 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Teva's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Dec 29, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notice of Service filed by Dr. Reddy's Laboratories Inc. and Dr. Reddy's Laboratories, Ltd. at D.I. 44 has been removed from the docket. This filing lacked reference in the caption to the MDL matter it relates with. Defendants shall correct the notice and refile in this action as well as the MDL. (nms) |
| Dec 29, 2021 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Lupin Limited and Lupin Pharmaceuticals, Inc.'s Production of Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John) |
| Dec 29, 2021 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Default Standard Paragraph 3 and 4(b) Disclosures filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) |
| Dec 29, 2021 | 47 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Bayer AG, Bayer Pharma AG.(Fahnestock, Derek) |
| Dec 29, 2021 | 48 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Dec 27, 2021 | 43 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Initial Disclosures of Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc. Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc.'s core technical documents filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) |
| Dec 20, 2021 | 42 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE of Voluntary Dismissal by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc. as to Taro's Counterclaims as to U.S. Patent 9,415,053 (Without Prejudice) (Vrana, Robert) |
| Dec 17, 2021 | 41 | Objections (13) Docket Text: Answer to Answer to Complaint and Counterclaim, Bayer AG, Bayer Pharma AG, and Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/20/2021 (nms). |
| Dec 15, 2021 | N/A | Remark - MDL Notice to Counsel (0) Docket Text: NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | 39 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 26(a)(1) Initial Disclosures filed by Mylan Pharmaceuticals Inc., Mylan Inc..(Palapura, Bindu) |
| Dec 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [38] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Counterclaims. Signed by Judge Richard G. Andrews on 12/13/2021. (nms) |
| Dec 10, 2021 | 38 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 17, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Dec 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [35] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Counterclaims to December 10, 2021. Signed by Judge Richard G. Andrews on 12/6/2021. (nms) |
| Dec 6, 2021 | 36 | Proposed Order (30) Docket Text: PROPOSED Stipulated Protective Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/6/2021 (nms). |
| Dec 6, 2021 | 37 | Order (30) Docket Text: SO ORDERED Granting [36] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 12/6/2021. (nms) |
| Dec 3, 2021 | 35 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 10, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Nov 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [33] STIPULATION TO EXTEND TIME to submit a proposed Protective Order to December 6, 2021. Signed by Judge Richard G. Andrews on 11/30/2021. (nms) |
| Nov 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [32] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 3,2021. Signed by Judge Richard G. Andrews on 11/29/2021. (nms) |
| Nov 29, 2021 | 33 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed Protective Order to December 6, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Nov 29, 2021 | 34 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Nov 24, 2021 | 32 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims to December 3, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Nov 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [31] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 11/24/2021; Bayer Pharma AG answer due 11/24/2021; Janssen Pharmaceuticals, Inc. answer due 11/24/2021). Signed by Judge Richard G. Andrews on 11/12/2021. (nms) |
| Nov 11, 2021 | 31 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 11/12/2021 (nms). |
| Nov 10, 2021 | 29 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Disclosures of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) |
| Nov 10, 2021 | 30 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Rule 26(a) Initial Disclosures filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd..(Ormerod, Eve) |
| Nov 9, 2021 | 28 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Initial Disclosures and (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Nov 5, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Lupin's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) |
| Nov 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [26] MOTION for Pro Hac Vice Appearance of Attorney Jitty Malik, Ph.D., filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 11/3/2021. (nms) |
| Nov 3, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jitty Malik, Ph.D. for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Nov 3, 2021 | 26 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jitty Malik, Ph.D. - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of Jitty Malik, Ph.D.)(Haney, Megan) |
| Nov 3, 2021 | 26 | Certification of Jitty Malik, Ph.D. (1) |
| Oct 28, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Dov P. Grossman and Bruce R. Genderson for Bayer AG and Bayer Pharma AG added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Oct 27, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Oct 27, 2021 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Jennifer L. Hall to handle all discovery disputes including any that arise in connection with expert reports. (nms) |
| Oct 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [25] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 11/11/2021; Bayer Pharma AG answer due 11/11/2021; Janssen Pharmaceuticals, Inc. answer due 11/11/2021). Signed by Judge Richard G. Andrews on 10/27/2021. (nms) |
| Oct 27, 2021 | 22 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. The case will be referred to a Magistrate Judge to handle all discovery disputes. The actions are consolidated for all purposes, including trial, and all papers shall be filed in C.A. 21-314 only. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 3/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A Bench Trial is set to start 5/30/2023 at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 10/28/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 10/27/2021. (ceg) |
| Oct 27, 2021 | 25 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims (D.I. 11) to November 11, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Oct 26, 2021 | 21 | Main Document (15) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 10/26/2021 (nms). |
| Oct 26, 2021 | 21 | Letter to The Honorable Richard G. Andrews (1) |
| Sep 27, 2021 | 20 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 10/28/2021, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/27/2021. (nms) |
| Aug 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 18 in 21-cv-1000-RGA; D.I. 17 in 21-cv-1001-RGA; D.I. 19 in 21-cv-314-RGA; D.I. 14 in 21-cv-732-RGA) MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Aug 27, 2021 | 19 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Jun 30, 2021 | 18 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove S. Isaac Olson as co-counsel. Reason for request: no longer with the firm. (Blumenfeld, Jack) |
| Jun 25, 2021 | 17 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Guylaine Hache as co-counsel. Reason for request: no longer associated with the case. (Haney, Megan) |
| May 24, 2021 | 16 | Answer to Counterclaim (8) Docket Text: ANSWER to [14] Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 5/24/2021 (nms). |
| May 4, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jillian M. Schurr, Lance A. Soderstrom, Deepro R. Mukerjee for Lupin Limited,for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| May 3, 2021 | 14 | Answer to Complaint (22) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John) Modified on 5/4/2021 (nms). |
| May 3, 2021 | 15 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Mar 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares, filed by Bayer Pharma AG, Bayer AG, and[13] MOTION for Pro Hac Vice Appearance of Attorney S. Isaac Olson, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/16/2021. (nms) |
| Mar 16, 2021 | 12 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek) |
| Mar 16, 2021 | 13 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney S. Isaac Olson - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Mar 11, 2021 | 11 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Haney, Megan) |
| Mar 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Lance A. Soderstrom, Deepro Mukerjee, Guylaine Hache and Jillian M. Schurr, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/8/2021. (nms) |
| Mar 8, 2021 | 10 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lance A. Soderstrom, Deepro Mukerjee, Guylaine Hache and Jillian M. Schurr - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of Lance A. Soderstrom, # (2) Certification of Deepro Mukerjee, # (3) Certification of Guylaine Hache, # (4) Certification of Jillian M. Schurr)(Phillips, John) |
| Mar 8, 2021 | 10 | Certification of Lance A. Soderstrom (1) |
| Mar 8, 2021 | 10 | Certification of Deepro Mukerjee (1) |
| Mar 8, 2021 | 10 | Certification of Guylaine Hache (1) |
| Mar 8, 2021 | 10 | Certification of Jillian M. Schurr (1) |
| Mar 4, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Lupin Limited waiver sent on 3/3/2021, answer due 5/3/2021. (Fahnestock, Derek) |
| Mar 4, 2021 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Lupin Pharmaceuticals, Inc. waiver sent on 3/3/2021, answer due 5/3/2021. (Fahnestock, Derek) |
| Mar 3, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Mar 2, 2021 | 7 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (amf) |
| Mar 1, 2021 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3554685.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(amf) |
| Mar 1, 2021 | 1 | Exhibit A (26) |
| Mar 1, 2021 | 1 | Civil Cover Sheet (1) |
| Mar 1, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Mar 1, 2021 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (amf) |
| Mar 1, 2021 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/29/2021. Date of Expiration of Patent: 1/31/2039. Thirty Month Stay Deadline: N/A* (*U.S. Patent No. 7,157,456 expires August 28, 2024.) (amf) |
| Mar 1, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (amf) |
| Mar 1, 2021 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (amf) |
| Mar 1, 2021 | 1 | Complaint* (1) |
